在外周血液单核细胞中具有有限激活的高TFEB表达反映了帕金森病中溶解体酶动态的改变
Yasuaki Mizutani1, Kazuki Nawashiro2, Souta Ito2
1Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Neurobiology of disease
|October 24, 2025
概括
帕金森病 (PD) 在周围血液细胞中表现出高的TFEB表达,但这种反应可能不足,导致酶释放受损,并表明PD中的系统性溶解体功能障碍.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- lysosomal 功能障碍是帕金森病 (PD) 的一个已知的标志.
- 在PD中这种 lysosomal 功能障碍的外围指标在很大程度上仍然没有表征.
研究的目的:
- 为了研究帕金森病中外围 lysosomal 酶的概况.
- 检查转录因子EB (TFEB) 在调节PD患者这些外周溶酶体标志物的作用.
主要方法:
- 评估了PD患者和对照者的外周血液单核细胞 (PBMC) 和血清中的 lysosomal hydrolase活动 (GLA,β-mannosidase) 和TFEB水平.
- 使用度测定和蛋白质水平通过ELISA量化酶活性.
- 通过测量其酸化水平,评估TFEB激活状态.
主要成果:
- 在PD患者的PBMC中发现了升高的α-galactosidase A (GLA) 活性和蛋白质,与β-mannosidase不同.
- 增加的TFEB蛋白度与PD中更高的溶酶蛋白水平相关.
- 降低了血清对PBMC的GLA比率,表明PD患者的PBMC酶释放受损.
结论:
- 在PBMC中提升的TFEB表达可能代表PD中补偿性的细胞应激反应.
- 功能性TFEB活性不足可能会限制 lysosomal酶释放.
- 与外围TFEB相关的溶酶体异常可以作为帕金森病中系统性自-溶酶体路径失调的生物标志物.
关键词:
Lysosomal 酸盐酸酶是一种溶解体酸酶.帕金森病是帕金森病的一种.周围血液中的单核细胞.转录因子EB是EB的转录因子.转录因子EB的酸化状态α-银酸酶 A 是一个α-银酸酶 A.这就是β-mannosidase.更多相关视频
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
1.2K
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
17.3K
相关概念视频
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:37Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
01:24Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K